Anika Therapeutics Inc (NASDAQ:ANIK)

45.35
BATS BZX Real-Time Price
As of 12:11pm ET
 -0.18 / -0.40%
Today’s Change
42.51
Today|||52-Week Range
69.81
-15.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$786.0M

Company Description

Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration and wound healing. The company's products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Contact Information

Anika Therapeutics, Inc.
32 Wiggins Avenue
Bedford Massachusetts 01730
P:(781) 457-9000
Investor Relations:
(781) 305-9713

Employees

Shareholders

Other institutional44.61%
Mutual fund holders42.09%
Individual stakeholders14.60%

Top Executives

Joseph G. DarlingPresident, Chief Executive Officer & Director
Sylvia CheungChief Financial Officer, Secretary & Treasurer
Edward S. AhnChief Technology & Strategy Officer
Steven J. ChartierVice President-Regulatory & Clinical Affairs
Steven CyrVice President-Human Resources